Molecular Diagnostics Market to Reach USD 13.81 Billion By 2026
Market Summary
Rising number of cancer cases, growing incidence of infectious diseases, strong government funding for medical science and the increasing application of patient-specific treatments are key factors contributing to high CAGR of Molecular Diagnostics during the forecast period. Market Size – USD 7.28 Billion in 2018, Market Growth - CAGR of 8.2%, Market Trends – impressive growth in colorectal cancer molecular diagnostics market According to the current analysis of Reports and Data, the global Molecular Diagnostics market was valued at USD 7.28 Billion in 2018 and is expected to reach USD 13.81 Billion by year 2026, at a CAGR of 8.2%.
Market Summary Our Approach The increasing efficiency of clinical trials, growing incidence of infectious and neurological diseases, and technological advancements in molecular pathology are major driving factors being the growth of the market. The increasing government aid for research and establishment of advanced testing facilities is also supporting the growth of the market.
The developing economies of India and China face some challenges in the form of the lack of a well-built procedural system for approvals, which hinders the growth of the molecular diagnostics market. Moreover, a shortage of skilled medical professionals is also limiting the growth of the market in many countries.
Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/945
Market Summary Our Approach
Key Players Are Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., Cepheid For the purpose of this report, Reports and Data has segmented the Molecular Diagnostics market on the basis of product and service, technology, application, end use, and region: Product and Service (Revenue, USD Million; 2016–2026) • Reagents and Kits • Instruments • Services and Software Technology (Revenue, USD Million; 2016–2026) • Polymerase Chain Reaction (PCR) • Isothermal Nucleic Acid Amplification Technology (INAAT) • DNA Sequencing & Next-Generation Sequencing (NGS) • in Situ Hybridization • DNA Microarray • Other Technologies
Market Summary Our Approach Application (Revenue, USD Million; 2016–2026) • Infectious Diseases • Oncology • Genetic Tests • Others End Use (Revenue, USD Million; 2016–2026) • Hospital and Academic Laboratories • Reference Laboratories • Others Regional Outlook (Revenue in USD Million; 2016–2026) • North America • Europe • Asia Pacific • Middle East and Africa • Latin America Order Now: https://www.reportsanddata.com/checkout-form/945
About Us About OurUs Approach
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail:
[email protected]
